Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2086 AL 2100

Risk Disclosure in Prodromal Parkinson's Disease

Schaeffer E, Toedt I, Köhler S, Rogge A, Berg D.

Mov Disord. 2021 Dec;36(12):2833-2839. doi: 10.1002/mds.28723. Epub 2021 Aug 5.

Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson's disease (MARK-PD)

Niemann L, Lezius S, Maceski A, Leppert D, Englisch C, Schwedhelm E, Zeller T, Gerloff C, Kuhle J, Choe CU.

Parkinsonism Relat Disord. 2021 Sep;90:44-48. doi: 10.1016/j.parkreldis.2021.07.028. Epub 2021 Jul 29.

Striatal Control of Movement: A Role for New Neuronal (Sub-) Populations?

Fieblinger T.

Front Hum Neurosci. 2021 Jul 20;15:697284. doi: 10.3389/fnhum.2021.697284. eCollection 2021.

Genomic Mosaicism Formed by Somatic Variation in the Aging and Diseased Brain

Costantino I, Nicodemus J, Chun J.

Genes (Basel). 2021 Jul 14;12(7):1071. doi: 10.3390/genes12071071.

Rat Models of Vocal Deficits in Parkinson's Disease

Krasko MN, Hoffmeister JD, Schaen-Heacock NE, Welsch JM, Kelm-Nelson CA, Ciucci MR.

Brain Sci. 2021 Jul 13;11(7):925. doi: 10.3390/brainsci11070925.

Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer's Disease

Villavicencio Tejo F, Quintanilla RA.

Antioxidants (Basel). 2021 Jul 2;10(7):1069. doi: 10.3390/antiox10071069.

Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways

Maiese K.

Biomolecules. 2021 Jul 9;11(7):1002. doi: 10.3390/biom11071002.

Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?

Gammon D, Cheng C, Volkovinskaia A, Baker GB, Dursun SM.

Biomolecules. 2021 Jul 15;11(7):1030. doi: 10.3390/biom11071030.

Animal Models of Autosomal Recessive Parkinsonism

Bastioli G, Regoni M, Cazzaniga F, De Luca CMG, Bistaffa E, Zanetti L, Moda F, Valtorta F, Sassone J.

Biomedicines. 2021 Jul 13;9(7):812. doi: 10.3390/biomedicines9070812.

Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?

Tan LY, Yeo XY, Bae HG, Lee DPS, Ho RC, Kim JE, Jo DG, Jung S.

Life (Basel). 2021 Jul 15;11(7):698. doi: 10.3390/life11070698.

Microbiota Gut-Brain Axis in Ischemic Stroke: A Narrative Review with a Focus about the Relationship with Inflammatory Bowel Disease

Sinagra E, Pellegatta G, Guarnotta V, Maida M, Rossi F, Conoscenti G, Pallio S, Alloro R, Raimondo D, Pace F, Anderloni A.

Life (Basel). 2021 Jul 19;11(7):715. doi: 10.3390/life11070715.

Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments

Mishima T, Fujioka S, Morishita T, Inoue T, Tsuboi Y.

J Pers Med. 2021 Jul 10;11(7):650. doi: 10.3390/jpm11070650.

Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors

Metta V, Batzu L, Leta V, Trivedi D, Powdleska A, Mridula KR, Kukle P, Goyal V, Borgohain R, Chung-Faye G, Chaudhuri KR.

J Pers Med. 2021 Jul 19;11(7):680. doi: 10.3390/jpm11070680.

Modulation of Neuroinflammation by the Gut Microbiota in Prion and Prion-Like Diseases

Trichka J, Zou WQ.

Pathogens. 2021 Jul 13;10(7):887. doi: 10.3390/pathogens10070887.

Parkinson's Disease: A Prionopathy?

Vascellari S, Manzin A.

Int J Mol Sci. 2021 Jul 27;22(15):8022. doi: 10.3390/ijms22158022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias